Last edition
News about "active pharmaceutical ingredients (APIs)"
Cambridge Isotope Laboratories (CIL), a subsidiary of Otsuka Pharmaceutical (Japan), has launched ISOAPI-D, a unified brand of deuterated intermediates for active pharmaceutical ingredient (API) synthesis, at CPhI Frankfurt.
Active Pharmaceutical Ingredients (APIs) | 29/10/2025 | By Dineshwori
USFDA Concludes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification
Dr. Reddy’s Laboratories has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practice (GMP) and Pre-Approval Inspection (PAI) at its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.
Active Pharmaceutical Ingredients (APIs) | 21/10/2025 | By Dineshwori | 135
Ipca Laboratories Expands Global Footprint with New German Subsidiary
Ipca Laboratories has announced the incorporation of its wholly owned subsidiary, Ipca Pharmaceuticals GmbH, in the Federal Republic of Germany with an initial paid-up capital of Euro 25,000.
Active Pharmaceutical Ingredients (APIs) | 16/10/2025 | By Dineshwori | 108
Aurobindo Pharma Expands Business in Malaysia with New Subsidiary
Aurobindo Pharma has announced the incorporation of a new wholly owned subsidiary, Aurobindo Pharma (Malaysia) SDN. BHD., through its subsidiary Helix Healthcare B.V.
Active Pharmaceutical Ingredients (APIs) | 18/09/2025 | By Dineshwori | 218
FDA Launches 'Green List' to Crack Down on Illegal GLP-1 API Imports
The US Food and Drug Administration (FDA) has created a new “green list” import alert to stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the US market.
Active Pharmaceutical Ingredients (APIs) | 09/09/2025 | By Dineshwori | 481
India's Push for API Self-Reliance Under the PLI Scheme
India’s Production Linked Incentive (PLI) scheme for bulk drugs and key starting materials is transforming the country’s pharmaceutical manufacturing landscape, pushing the sector toward self-reliance.
Active Pharmaceutical Ingredients (APIs) | 31/08/2025 | By Darshana | 671
Senores Pharmaceuticals Appoints Manohar Lalge as President - Research & Development
Senores Pharmaceuticals Ltd. (SPL) has appointed Manohar Lalge as President – Research and Development.
Active Pharmaceutical Ingredients (APIs) | 20/08/2025 | By Dineshwori | 182
FDA Launches PreCheck Program to Boost US Drug Manufacturing
The US Food and Drug Administration (USFDA) has unveiled a new program aimed at strengthening the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of manufacturing sites in the United States.
Active Pharmaceutical Ingredients (APIs). | 11/08/2025 | By Dineshwori
FDA Launches PreCheck Program to Boost US Drug Manufacturing
The US Food and Drug Administration (USFDA) has unveiled a new program aimed at strengthening the domestic pharmaceutical supply chain by increasing regulatory predictability and facilitating the construction of manufacturing sites in the United States.
Active Pharmaceutical Ingredients (APIs) | 11/08/2025 | By Dineshwori
Governor of New York State Kathy Hochul has announced that Garonit Pharmaceutical, a global manufacturer of antiseptic products and health care solutions, will establish a state-of-the-art, 200,000-square-foot pharmaceutical manufacturing facility in New Windsor, Orange County.
Active Pharmaceutical Ingredients (APIs) | 05/08/2025 | By Dineshwori | 168
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy